Ocumension Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Ocumension Therapeutics has a total shareholder equity of CN¥2.8B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥3.0B and CN¥257.7M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥972.91m |
| Equity | CN¥2.77b |
| Total liabilities | CN¥257.68m |
| Total assets | CN¥3.03b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 5DG's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥224.9M).
Long Term Liabilities: 5DG's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥32.7M).
Debt to Equity History and Analysis
Debt Level: 5DG is debt free.
Reducing Debt: 5DG currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 5DG has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 5DG has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.